Pfizer Inc. Recall: Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Via
Pfizer Inc. Recall: Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Via is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Pfizer Inc.; Product: Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Vial, Rx only, Sterile, Manufactured for: Hospira, Inc, La
| Recalling firm | Pfizer Inc. |
|---|---|
| Product | Argatroban Injection, 250 mg/2.5 mL (100 mg/mL), 2.5 mL Single-use Vial, Rx only, Sterile, Manufactured for: Hospira, Inc, Lake Forest, IL 60045 USA. NDC: 0409-1140-01 |
| Reason for recall | Failed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time point |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | Nationwide USA |
| Recall initiated | 20180828 |
| Recall number | D-1184-2018 |
| Category | drug |
| State | NY |
| Country | United States |
$29/mo
Try RecallGuard →